| Vimentin in cancer and its potential as a molecular target for cancer therapy A Satelli, S Li Cellular and molecular life sciences 68, 3033-3046, 2011 | 1642 | 2011 |
| Epithelial–mesenchymal transitioned circulating tumor cells capture for detecting tumor progression A Satelli, A Mitra, Z Brownlee, X Xia, S Bellister, MJ Overman, S Kopetz, ... Clinical Cancer Research 21 (4), 899-906, 2015 | 232 | 2015 |
| Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients A Satelli, IS Batth, Z Brownlee, C Rojas, QH Meng, S Kopetz, S Li Scientific reports 6 (1), 28910, 2016 | 182 | 2016 |
| Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule–and cell-surface vimentin–based methods for monitoring breast cancer therapeutic response A Satelli, Z Brownlee, A Mitra, QH Meng, S Li Clinical chemistry 61 (1), 259-266, 2015 | 182 | 2015 |
| Universal marker and detection tool for human sarcoma circulating tumor cells A Satelli, A Mitra, JJ Cutrera, M Devarie, X Xia, DR Ingram, D Dibra, ... Cancer research 74 (6), 1645-1650, 2014 | 161 | 2014 |
| EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression A Satelli, I Batth, Z Brownlee, A Mitra, S Zhou, H Noh, CR Rojas, H Li, ... Oncotarget 8 (30), 49329, 2017 | 132 | 2017 |
| Galectin‐4 functions as a tumor suppressor of human colorectal cancer A Satelli, PS Rao, S Thirumala, US Rao International journal of cancer 129 (4), 799-809, 2011 | 122 | 2011 |
| IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice SL Abhisek Mitra, Arun Satelli, Jun Yan, Xia Xueqing, Mihai Gagea ... Hepatology, 2014 | 111 | 2014 |
| Varied expression and localization of multiple galectins in different cancer cell lines A Satelli, PS Rao, PK Gupta, PR Lockman, KS Srivenugopal, US Rao Oncology reports 19 (3), 587-594, 2008 | 103 | 2008 |
| Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers A Mitra, A Satelli, X Xia, J Cutrera, L Mishra, S Li International journal of cancer 137 (2), 491-496, 2015 | 95 | 2015 |
| Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanisms PS Rao, A Satelli, M Moridani, M Jenkins, US Rao International journal of cancer 130 (11), 2703-2714, 2012 | 92 | 2012 |
| Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells H Noh, J Hu, X Wang, X Xia, A Satelli, S Li Cell Communication and Signaling 13, 1-12, 2015 | 68 | 2015 |
| Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells A Satelli, US Rao Cancer letters 301 (1), 38-46, 2011 | 57 | 2011 |
| Translating immunopeptidomics to immunotherapy‐decision‐making for patient and personalized target selection J Fritsche, B Rakitsch, F Hoffgaard, M Römer, H Schuster, DJ Kowalewski, ... Proteomics 18 (12), 1700284, 2018 | 41 | 2018 |
| Potential function of exogenous vimentin on the activation of Wnt signaling pathway in cancer cells A Satelli, J Hu, X Xia, S Li Journal of Cancer 7 (13), 1824, 2016 | 28 | 2016 |
| RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways PS Rao, A Satelli, S Zhang, SK Srivastava, KS Srivenugopal, US Rao Proteomics 9 (10), 2776-2787, 2009 | 28 | 2009 |
| Cell surface vimentin‐positive circulating tumor cell‐based relapse prediction in a long‐term longitudinal study of postremission neuroblastoma patients IS Batth, L Dao, A Satelli, A Mitra, S Yi, H Noh, H Li, Z Brownlee, S Zhou, ... International journal of cancer 147 (12), 3550-3559, 2020 | 23 | 2020 |
| 959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses–clinical update on the ACTengine … M Wermke, AM Tsimberidou, M Ali, A Mayer-Mokler, A Satelli, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A1009-A1009, 2021 | 15 | 2021 |
| Feasibility and safety of personalized, multi-target, adoptive cell therapy (IMA101): first-in-human clinical trial in patients with advanced metastatic cancer AM Tsimberidou, K Guenther, BS Andersson, R Mendrzyk, A Alpert, ... Cancer Immunology Research 11 (7), 925-945, 2023 | 6 | 2023 |
| Prognostic value of cell-surface vimentin-positive CTCs in pediatric sarcomas L Dao, D Ragoonanan, I Batth, A Satelli, J Foglesong, J Wang, W Zaky, ... Frontiers in Oncology 11, 760267, 2021 | 5 | 2021 |
